GlassScriptPhysician profile
Connor Hoban
NPI 1770044794
$36,431.00
in general payments reported to CMS, 2019-2025
9 companies · $9,299 in 2025
The $9,299 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $287 · 2024: $27K · 2025: $9,299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $33K · Food and Beverage: $1,592 · Travel and Lodging: $1,505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $33,333.34 |
| Food and Beverage | $1,592.47 |
| Travel and Lodging | $1,505.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $21,737.19 | 2024-2025 | |
| Smith+Nephew, INC. | $13,333.34 | 2024-2025 | |
| Stryker Corporation | $463.47 | 2025 | Knotilus Anchor, 3.5mm, Cinchlock, T2 Alpha |
| Mf Med | $300.52 | 2025 | |
| Vericel Corporation | $173.97 | 2023-2025 | Maci |
| Si-Bone, INC. | $144.67 | 2023 | |
| Heron Therapeutics, INC. | $119.70 | 2023 | Zynrelef |
| Convatec INC. | $99.58 | 2024 | |
| Depuy Synthes Sales INC. | $58.56 | 2024 | Na, Va-Lcp, Twistr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connor Hoban listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.